Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYDY - CytoDyn: Suitable For Trading Not Investing

CYDY - CytoDyn: Suitable For Trading Not Investing

CytoDyn Inc
  • In 2019, CytoDyn touted initial approval of leronlimab as a blockbuster combination therapy for HIV.
  • CytoDyn has encountered a long string of obstacles in presenting leronlimab to the FDA for its consideration.
  • Leronlimab's current status in its quest for approval as combination therapy is a developing situation.
  • The ebb and flow of CytoDyn's new and exciting projects have a familiar cadence.
  • CytoDyn's finances have been touch and go for the bulk of its existence.

For further details see:

CytoDyn: Suitable For Trading Not Investing
Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...